Stockscreener 앱 받기
2.22
2.63%
-0.06
시간 외 거래:
2.20
-0.02
-0.90%
Phio Pharmaceuticals Corp 주식(PHIO)의 최신 뉴스
Phio Pharmaceuticals (PHIO) Stock Price, News & Analysis - MarketBeat
Phio Pharmaceuticals CEO to Present Breakthrough Cancer Treatment at Renmark Virtual Roadshow - StockTitan
Phio Pharmaceuticals Announces Closing of $1.83 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile
Phio Pharmaceuticals Secures $1.83M Direct Offering to Advance Cancer Treatment Pipeline - StockTitan
We Asked Retail What's Next For Phio Pharma After Monday's Blistering Rally: Most See More Room To Run - MSN
Phio Pharmaceuticals Raises $1.83M in Direct Offering with Warrant Coverage at $3.00/Share - StockTitan
Stock market news: Phio Pharmaceuticals +50.19%, DatChat +46.01% among top gainers during mid day trading - Business Upturn
Stock market today: Phio Pharmaceuticals -20.76%, Soligenix -20.15% among biggest losers in early trading - Business Upturn
Phio Pharmaceuticals Raises $2.5M Through Direct Offering at $3.00 Per Share - StockTitan
Phio Pharmaceuticals sharply lower on equity offering - MSN
Stock market news: Phio Pharmaceuticals -50.61%, Salarius Pharmaceuticals -28.61% among biggest losers during mid day trading - Business Upturn
Stock market news: Eterna Therapeutics posted gain of 100.87% while Phio Pharmaceuticals saw loss of 50.44% during mid day trading - Business Upturn
What's Going On With Phio Pharmaceuticals Stock Today? - Benzinga
Stock market today: Phio Pharmaceuticals -41.48%, Aehr Test Systems -26.86% among biggest losers in early trading - Business Upturn
Stock market today: Eterna Therapeutics gain over 136.63% while Phio Pharmaceuticals plunged by 40.25% in early trading - Business Upturn
Nasdaq Jumps 150 Points; US Producer Prices Increase 0.2% In December - Benzinga
Phio Pharmaceuticals Announces $3.19 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile
Phio stock surged 330%: Phio reports 100% tumor clearance - Markets.com
Stocks to Watch in 2025: PHIO, LPTH, KAVL, Promising Innovations, Growth Opportunities, Etc. … more inside - newschannelnebraska.com
Phio Pharma Stock Quadruples On Positive Data From Cancer Treatment Trial: Retail’s Elated - MSN
Phio Pharmaceuticals skyrockets on skin cancer drug trial success - Mugglehead
Stocks to Watch in 2025: PHIO, LPTH, KAVL, Promising Innovations, Growth Opportunities, Etc. ... more inside - openPR
Gold Down Over 1%; Salarius Pharmaceuticals Shares Surge - Benzinga
Unlocking the Surge! Phio Pharmaceuticals Surprises Everyone with 300% Stock Surge - Elblog.pl
Cancer-Focused Phio Pharmaceuticals Stock Gains 300% On MondayHere's Why - Benzinga
Stock market news: Phio Pharmaceuticals +296.88%, Salarius Pharmaceuticals +153.67% among top gainers during mid day trading - Business Upturn
Stock market news: Shallgo saw rise of 286.81% while Kairos Pharma was up by 176.47% during mid day trading - Business Upturn
Stocks to Watch in 2025: PHIO, LPTH, KAVL and more - Markets.com
Phio reports complete tumor clearance in two cancer patients By Investing.com - Investing.com South Africa
US Stocks Mixed; Nasdaq Down Over 1% - Benzinga
Stock market today: Phio Pharmaceuticals +289.93%, Sage Therapeutics +34.95% among the top gainers in early trading - Business Upturn
Phio Pharma Shares Triple After Positive Trial Data for Cancer Treatment - MarketWatch
Pre-Market Surge For Phio Pharmaceuticals Following Clinical Success - Stocks Telegraph
PHIOPhio Pharmaceuticals Corp. Latest Stock News & Market Updates - StockTitan
Phio reports complete tumor clearance in two cancer patients - Investing.com
Phio Pharmaceuticals Announces Promising Results of Second Cohort from Its Ongoing Clinical Study of PH-762 - Newsfile
Phio's Cancer Drug PH-762 Achieves Complete Tumor Clearance in Phase 1b Trial Patients - StockTitan
Stock market today: Kairos Pharma saw rise of 130.20% and Salarius Pharmaceuticals was up by 180.52% in early trading - Business Upturn
Phio reports potential hyperpigmentation treatment success - Investing.com
Comfort Systems USA (FIX-N) QuotePress Release - The Globe and Mail
Phio Pharmaceuticals Announces Publication in Clinical, Cosmetic and Investigational Dermatology - Newsfile
Phio's RXI-231 Shows Promise in Groundbreaking Hyperpigmentation Treatment Study - StockTitan
Why ACADIA Pharmaceuticals Inc. (ACAD) Is Skyrocketing - Yahoo Finance
Phio Pharmaceuticals Corp. Announces Positive Safety Monitoring Committee Recommendation to continue to Third Dose Cohort in its Clinical Study of PH-762 - Marketscreener.com
Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile
Phio Pharmaceuticals Announces $480K Direct Offering with Warrant Coverage to Boost Working Capital - StockTitan
Phio Pharmaceuticals Rallies Following Key Trial and Funding Updates - Stocks Telegraph
Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket - Benzinga
As FedEx plans to spin off freight, can it cut costs even more? - Yahoo Finance
Phio stock hits 52-week low at $2.13 amid market challenges - Investing.com
Phio Pharmaceuticals Raises $1.15M Through Strategic Direct Offering and Warrant Placement - StockTitan
5.49%
0.79%
자본화:
|
볼륨(24시간):